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A B S T R A C T
The primary goal of this paper is to evaluate the efficiency of the Colorectal Cancer Screening Program in the Osijek-
-Baranja County. The screening method for early detection of colorectal cancer was the guaiac Faecal Occult Blood Test
(gFOBT) and colonoscopy for gFOBT positive finding. The target population were asymptomatic subjects at average
risk, aged 50–74. The responding rate was 20.3% (14.9% of men and 19.3% of women). The percentage of gFOBT positive
tests was 8.5% (11.2% of men and 6.6% of women). From the 1,657 individuals who were invited to further assessment
(884 men and 773 women), 1,157 underwent a colonoscopy exam (649 men and 508 women). We can conclude that the re-
sponse to FOBT in our county was extremely poor. 83 carcinomas were found, with almost double findings among men
than among women. Our population has a significantly higher number of men with malignant and premalignant chan-
ges when compared with women. Considering the higher incidence among men, as well as an increase in incidence in the
entire population, we have to take care that our public health programmes are being created with this taken into account,
as to increase the response rate, especially among those with a higher risk of developing a disease.
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Introduction
Colorectal cancer (CRC) is the third most prevalent
human cancer worldwide, with 1 million estimated new
cases annually1. Low socioeconomic status (SES) is asso-
ciated with an increased risk for the development of
colorectal cancer; one study estimated the CRC risk to be
about 30 percent increased in the lowest as compared to
the highest SES quintile1. Unhealthy behaviour such as
physical inactivity, unhealthy diet, smoking, and obesity
are thought to account for a substantial proportion (esti-
mates of one-third to one-half) of the socioeconomic dis-
parity in risk of new onset colorectal cancer2–5. CRC inci-
dence and mortality rates vary markedly around the
world. Globally, CRC is the third most commonly diag-
nosed cancer in males and the second in females, with
over 1.2 million new cases and 608,700 deaths estimated
to have occurred in 20086. The highest incidence rates
are in Australia and New Zealand, Europe and North
America, and the lowest rates are found in Africa and
South-Central Asia1. These geographic differences appear
to be attributable to differences in dietary and environ-
mental exposures that are imposed upon a background of
genetically determined susceptibility. The incidence of
CRC is higher for men, and the risk of the disease in-
creases with age, as the majority of cases are diagnosed
in patients more than 50 years of age7. From 2005–2009,
the median age at diagnosis for cancer of the colon and
rectum was 69 years of age8.
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In Croatia there has been an increase in CRC inci-
dence from 34.5/100,000 (1990) to 64/100,000 (2005), as
well as an increase in mortality from 21.9/100,000 (1990)
to 40.6/100,000 (2006)9–25. An increase in incidence can
also be seen in the Osijek-Baranja County (OBC) (Table 1).
Considering our county is in a depopulation phase,
and that the age structure is continuing to lean toward
older generations, a further increase in incidence of
colorectal carcinoma, as well as the ensuing burdening of
the health sector, can be expected.
In 2003, recommendations for screening programs
were issued by the Council of the European Union (EU).
A screening program of one sort or another has been im-
plemented in 19 of 27 EU countries. Response to the
screening is as follows: 52% in the United Kingdom26,
42% in France (2.7% positive)27, 48.0% in Italy (5.5% pos-
itive)28, 70.8% in Finland (women)29, 20% in the Czech
Republic30. In Croatia, The National Program of Preven-
tion and Early Detection of Colorectal Cancer started on
November 2007.
Material and Methods
The screening method for early detection of colorectal
cancer was the guaiac Faecal Occult Blood Test (gFOBT).
The target population ware asymptomatic population at
average risk, aged 50–74. The target population was
105,075 people, compromising 31.2% of the county’s pop-
ulation. The expected time of one screening cycle was 2
years. Invitation letters have been sent by mail. In an en-
velope, there are three gFOBT with instructions for their
use (because adenomatous polyps and cancers are thought
to bleed intermittently, gFOBT require four samples
from three different feces), a questionnaire about risk
factors and an educational brochure. The respondents
were given detailed instructions on how to diet before
sampling. The tests were processed without rehydration.
The analysis of data from the questionnaires will assess
the prevalence of risk factors in the population. Invited
people have been asked to mail applied testing-cards
back together with a filled out questionnaire. People test-
ing positive are invited for colonoscopy in the Clinical
Hospital Centre Osijek by mail.
The individuals who tested positive for gFOBT were
invited to undergo a colonoscopy examination. During
colonoscopy examination the premalignant lesions are
removed and the samples are sent for histopathological
analysis. The patients were referred to colonoscopy sur-
veillance if appropriate, depending on the results of the
analysis. The colonoscopy results were collected and ana-
lysed in the Institute of Public Health. In first year of
program implementation the central database for online
data input was established. The results of testing, colo-
noscopy and Question form collecting and input in the
County Institute of Public Health.
The histologic classification of polyps and cancers was
based on World Health Organization criteria31. Advanced
adenoma was defined as an adenoma with any of the fol-
lowing features: adenomas larger than 9 mm or with
villous component >20% or with high dysplasia 32,33. The
risk of malignancy within an adenomatous polyp corre-
lates with size, histologic type, and degree of dysplasia34.
Cancer was defined as the invasion of malignant cells
beyond the muscularis mucosae. Patients with intra-
mucosal carcinoma or carcinoma in situ were classified
as having high-grade dysplasia.
Statistical analysis
Contingency tables were used in the analysis. The
software SAS for Windows (version 8.2, SAS Institute
Inc, Cary, NC) was used for the analysis35.
Results
Until February 2013 we sent FOBT to 105,075 indi-
viduals (100.0% of target population); 48,678 men and
56,397 women. 8,609 (4.635 men and 3.974 women) had
an incorrect address, performed a colonoscopy or FOBT
in the year before the Program started, died or have de-
clared themselves unwilling to undergo testing (Table 2).
The responding rate (of those who received the invita-
tion) was 20.3% (14.9% of men and 19.3% of women).
The percentage of FOBT positive tests was 8.5% (11.2%
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TABLE 1
INCIDENCE OF CRC IN OSIJEK-BARANJA COUNTY PER
GENDER FROM 1991 UNTIL 2009
Year
Male Female All
N Rate N Rate N Rate
1991 52 29.3 64 33.7 116 31.6
1992 46 25.9 43 22.7 89 24.2
1993 55 31.0 51 26.9 106 28.9
1994 71 40.0 38 20.0 109 29.7
1995 60 33.8 40 21.1 100 27.2
1996 60 33.8 60 31.6 120 32.7
1997 66 37.2 82 43.2 148 40.3
1998 85 47.9 67 35.3 152 41.4
1999 90 50.7 80 42.1 170 46.3
2000 89 50.2 93 49.0 182 49.6
2001 85 53.6 96 55.9 181 54.8
2002 105 66.2 86 50.0 191 57.8
2003 115 72.5 91 53.0 206 62.3
2004 94 59.2 88 51.2 182 55.1
2005 101 63.7 76 44.2 177 53.6
2006 106 66.8 88 51.2 194 58.7
2007 119 75.0 89 51.8 208 62.9
2008 119 75.0 83 48.3 202 61.1
2009 117 73.7 81 47.1 198 59.9
All 1225 1018 2243
* – Source: Institute of Public Health Osijek-Baranja County,
N – number, Rate – rate/100,000
of men and 6.6% of women). From the 1,657 individuals
who were invited (884 men and 773 women) 1,157 under-
went a colonoscopy exam (649 men and 508 women).
87.6% had a pathological finding, 92.0% in men and
82.1% in women. There were 83 newly discovered carci-
nomas (7.2% of those who underwent colonoscopy), 599
polyps (51.8%), 196 haemorrhoids (16.9%), 87 diverticula
(7.5%) and 49 other diagnoses (4.2%). 306 polyps was ad-
vanced adenomas (26.4%). In 143 individuals the find-
ings were without pathological findings (12.4%).
Discussion
CRC is the second most frequent malignant disease in
developed countries36. It has been estimated that in
2006, 412,000 people were diagnosed with CRC in Euro-
pe, and 207,400 of them died of the disease37. In the
Osijek-Baranja County the National programme started
in 2007.
gFOBT and optical colonoscopy (OC) are currently
recommended for population-based screening programs
in Croatia38. Moreover, the European Guidelines on qual-
ity assurance for CRC screening has recently recom-
mended fecal immunochemical test (FIT) as the first
choice test in place of the guaiac test39. The reason for
choosing gFOBT was a big difference in price, as well as
the geographic characteristics of the country that pre-
vented transportation of FIT to the lab during the sched-
uled period (up to 12 hours since the sample collection).
Although the Programme stated an invitation cycle of
two years38, we are only concluding the first screening
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TABLE 2
No OF INVITED PERSONS, PERSONS WITH INCORRECT ADDRESSE, DIED, WHO PERFORMED A COLONOSKOPY OR FOBT IN THE





B. Incorrect addresses+died+who per-
formed a colonoscopy or FOBT done in
the past year+do not want
A – B
Male Female All subjects Male Female All subjects Male Female All subjects
55–59 11,121 11,212 22,333 792 721 1,513 11,913 11,933 20,820
55–59 11,121 11,212 22,333 792 721 1,513 11,913 11,933 20,820
60–64 14,492 15,683 30,175 1,563 1,180 2,743 16,055 16,863 27,432
65–69 6,383 7,821 14,204 757 634 1,391 7,140 8,455 12,813
70–74 11,163 16,056 27,219 1,229 1,165 2,394 12,392 17,221 24,825
70–74 11,163 16,056 27,219 1,229 1,165 2,394 12,392 17,221 24,825
All 48,678 56,397 105,075 4,635 3,974 8,609 53,313 60,371 96,466
TABLE 3
RESULTS OF NACIONAL PROGRAM OF EARLY DETECTION OF CRC IN OSIJEK-BARANJA COUNTY UNTIL FEBRUARY 2013 – ALL
Results Males Females All subjects
Invited subjects 53,313 60,371 96,466
Responders 7,955 11,645 19,600
Parattendance rate 14.9% 19.3% 20.3%
Faulty 60 152 212
FOBT positive 887 770 1,657
Positivity rate 11.2% 6.6% 8.5%
Patients invited to colonoscopy 884 773 1,657
Compliers to colonoscopy 649 508 1,157
Compliance % 73.4% 65.7% 69.8%
Number of cancers 61 22 83
Numbers of Advanced Adenomas 206 100 306
Positive predictive value (PPV) for cancer 9.4% 4.3% 7.2%
Positive predictive value (PPV) for advanced adenomas 31.7% 19.7% 26.4%
Detection rate (DR) for cancer 7.7‰ 1.9‰ 4.3‰
Detection rate (DR) for advanced adenomas 25.9‰ 8.6‰ 15.6‰
Detection rate (DR) for cancer and advanced adenomas 33.6‰ 10.5‰ 19.8‰
cycle. The reasons for this prolongation were problems in
implementation40, as well as an inadequate estimation of
health sector funds; for instance, an inadequate number
of colonoscopies and personnel in colonoscopy units. Up
until February 2013 response rate on gFOBT was 22.2%
(20.1% of men and 23.9% of women). If we compare the
response rate to that of other European countries (GB
52%26, France 42%27, Italy 48.0%28, Finland 70.8%29), we
can conclude that the response to FOBT in our county is
extremely poor, far poorer than expected, but still in line
with the rest of Croatia41.
The percent of gFOBT positive tests was 8.5%; 11.2%
of men and 6.6% of women. Up until now 1,157 colono-
scopy exams were conducted in the screening programme.
The average response rate to OC was 69.8% which is
far lower than in similar Programs in Europe28,. Perhaps
the reason for a low response rate to OC was an invita-
tion via mail and the insufficient education of the popula-
tion. Simultaneously with sending invitations to OC to
the respondent, a message to the GP about the invitation
was sent. Thus the GP had the ability to check the reason
for not responding to the invitation. The impact on the
response to OC was affected by poor preparation for the
examination. These subjects are then re-scheduled. One
part of the re-scheduled subjects was lost from the re-
cords because they came to OC with a GP referral.
Men had as high as 92.0% of pathological findings,
while women had 82.1%. 83 (7.2%) carcinoma were
found, with almost double findings among men (9.4%)
than among women (4.3%). Detection rate (DR) per
1,000 screened subjects for cancer was 4.3‰ (7.7‰ in
men and 1.9‰ in women) and for advanced adenomas
(AA) was 15.6‰ (25.9‰ in men and 8.6‰ in women)
which is much moor than e.g. in Italy28, USA42. DR for
cancer and advanced adenomas was 20.0‰ (33.7‰ in
men and 10.5‰ in women).
These results are slightly higher than those of similar
programmes in the Czech Republic10, while, for instance,
France had a higher percentage of cases with carcinoma
(10.6%), but a lower percentage when combined with pol-
yps (33.1%)43 than in our population. We can conclude
that our population has a significantly higher number of
men with malignant and premalignant changes when
compared with women. Considering only one fifth of the
population responded to the invite, a rough estimate is
that there is a five time larger number of people with ma-
lignant and premalignant lesions in the entire popula-
tion. Early detection means successful treatment and a
better quality of life44,45.
The implementation of similar programmes in the
world has shown a greater response rate among women
and higher socioeconomic classes46,47, as well as the influ-
ence of the chosen general practitioner (GP)48,49. Con-
sidering the higher incidence among men, as well as an
increase in incidence in the entire population, we have to
take care that our public health programmes are being
created with this taken into account, as to increase the
response rate, especially among those with a higher risk
of developing a disease.
Conclusions
We can conclude that the response to gFOBT in our
county is extremely poor, far poorer than expected, but
still in line with the rest of Croatia. 83 carcinomas were
found, with almost thrice findings among men than
among women. Our population has a significantly higher
number of men with malignant and premalignant chan-
ges when compared with women. Considering only one
fifth of the population responded to the invite, a rough
estimate is that there is a five time larger number of peo-
ple with malignant and premalignant lesions in the en-
tire population. Considering the higher incidence among
men, as well as an increase in incidence in the entire pop-
ulation, we have to take care that our public health
programmes are being created with this taken into ac-
count, as to increase the response rate, especially among
those with a higher risk of developing a disease.
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TABLE 4
RESULTS OF COLONOSCOPY IN NACIONAL PROGRAM OF EARLY DETECTION OF CRC IN OSIJEK-BARANJA COUNTY
UNTIL FEBRUARY 2013
Males Females All subjects
N % N % N %
Received a call for colonoscopy 884 53.3 773 46.7 1657 100.0
Insufficient preparation, died or give up 235 26.6 265 34.3 500 30.2
Performed the colonoscopy 649 73.4 508 65.7 1157 69.8
All subjects 884 100.0 773 100.0 1657 100.0
Normal findings 52 8.0 91 17.9 143 12.4
Carcinomas 61 9.4 22 4.3 83 7.2
Polip 379 58.4 220 43.3 599 51.8
Hemorrhoids 105 16.2 91 17.9 196 16.9
Diverticulosis 37 5.7 50 9.8 87 7.5
Other 15 2.3 34 6.7 49 4.2
All findings 649 100.0 508 100.0 1157 100.0
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PRVIH [EST GODINA IMPLEMENTACIJE PROGRAMA RANOG OTKRIVANJA RAKA DEBELOG
CRIJEVA U OSJE^KO-BARANJSKOJ @UPANIJI – MO@EMO LI BOLJE?
S A @ E T A K
Cilj ovog rada je prikazati rezultate Nacionalnog programa ranog otkrivanja raka debelog crijeva u Osje~ko-baranj-
skoj `upaniji koji je zapo~eo 2007. godine. Iako je bio predvi|en interval probira od dvije godine, prvi ciklus je zavr{en
nakon {est godina. Razlog ovog vremenskog ka{njenja su tehni~ke pote{ko}e u provedbi i neadekvatno procjenjeni
resursi prije po~etka Programa. Metoda skrininga je test na nevidljivo krvarenje u stolici, te kolonoskopija za osobe s
pozitivnim nalazom ovog testa. Do velja~e 2013. godine pozvano je 105 075 osoba u dobi 50 do 74 godina. Na kraju prvog
ciklusa odaziv je 20,3% (14.9% mu{karaca i 19,3% `ena). 8,5% osoba je bilo pozitivno na nevidljivo krvarenje (11,2%
mu{karaca i 6,6% `ena). Rezultati odaziva su zna~ajno manji od planiranih 60%. Na kolonoskopiju je pozvano 1657
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osoba (884 mu{karaca i 773 `ena) a odazvalo se 1157 osoba (649 mu{karaca i 508 `ena). U populaciji mu{karaca je
zna~ajno ve}i udio malignih i premalignih promjena. Obzirom da se na rano otkrivanje odazvala petina populacije,
gruba je procjena da je u populaciji pet puta vi{e osoba s malignim i premalignim lezijama. Iskustva u provo|enju
Nacionalnog programa potrebno je implementirati u slijede}e cikluse kako bi pove}ali odaziv, a time otkrili premaligne
promjene na vrijeme i pove}ali pre`ivljavanje oboljelih od kolorektalnog karcinoma, te pove}ali kvalitetu `ivota obo-
ljelih.
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